RAnalyticsLeadershipProject ManagementStrategic PlanningCommunicationDecision Making
About this role
Role Overview
Develop framework for opportunity and portfolio evaluation as part of annual 5-yr roadmap planning
Synthesize data across Market Intelligence and Product Strategy, Operations, Project Management, Tech, R&D, Finance and Data analytics teams
Evaluate strategic options across the molecular diagnostics portfolio, including product development, evidence generation, and infrastructure investments
Support portfolio prioritization decisions by assessing tradeoffs across risk, return, timing, and strategic fit
Update program and portfolio value for review at quarterly intervals and recommend project prioritization
Build and own enterprise financial models (DCF, NPV, IRR, scenario analysis) to assess long-term value creation of initiatives
Quantify the financial impact of potential R&D, operations, and product decisions
Partner with Finance and FP&A to align long-range plans with strategic priorities
Partner with Investor Relations to understand investor valuation perspectives of portfolio and financial decisions
Develop concise, executive-ready presentations and materials for senior leadership and board discussions
Translate financial information into clear recommendations
Support annual strategic planning and long-range planning processes
Requirements
Bachelor’s degree in Business, Finance, Economics, or STEM related field
4–7 years of experience in investment banking (healthcare group), or private equity
Expert-level proficiency in complex financial modeling and "clean-sheet" problem-solving
Experience working with ambiguous, incomplete data to support decision making
Excellent written and verbal communication skills
Experience in molecular diagnostics, life sciences, biotech, or healthcare (preferred)
Familiarity with diagnostics product development lifecycles, regulatory pathways, and reimbursement considerations (preferred)
Experience in corporate strategy and planning and/or strategic portfolio planning (preferred)
MBA or CFA designation is highly preferred (preferred)
Experience supporting executive or board-level strategy discussions (preferred)